临床研究
Copyright ©The Author(s) 2020.
世界华人消化杂志. 2020-11-28; 28(22): 1137-1144
在线出版 2020-11-28. doi: 10.11569/wcjd.v28.i22.1137
表4 各模型诊断纤维化和早期肝硬化的AUROC
模型肝纤维化(F2-3)95%置信区间P早期肝硬化(F4)95%置信区间P
AAR0.5390.501-0.5790.0700.6680.626-0.7100.000
APRI0.6480.611-0.6850.0000.6940.656-0.7320.000
API0.765a0.732-0.7960.0000.849abc0.824-0.8750.000
CDS0.6600.623-0.6970.0000.7400.702-0.7790.000
FIB40.747ab0.714-0.7800.0000.834abc0.806-0.8630.000
GPR0.771a0.739-0.8020.0000.825abc0.796-0.8540.000
S0.782a0.751-0.8130.0000.839abc0.811-0.8660.000
SPRI0.765a0.732-0.7970.0000.891a0.866-0.9150.000
ASPRI0.7960.766-0.8260.0000.9120.892-0.9330.000
FV0.8340.806-0.8610.0000.9280.911-0.9440.000

引文著录: 杨晴, 王岩, 关欣, 谷野, 李鲁平, 戴文颖, 卞丽, 尚宁. 无创模型在慢性乙型肝炎肝纤维化诊断中的价值. 世界华人消化杂志 2020; 28(22): 1137-1144